Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit
MyChart for medical appointments or to contact your provider.
Biography
I received my PhD in Molecular Pharmacology from the University of Illinois College of Medicine in 2017. I then completed my postdoctoral training at the National Cancer Institute, before accepting a faculty position in the MUSC Department of Cell and Molecular Pharmacology and Experimental Therapeutics in 2023. The RAS-MAPK pathway is hyperactivated in 30-40% of human cancers; however, there remains a dearth of effective drugs that target this pathway. The primary objective of our lab is to uncover new vulnerabilities in RAS-MAPK signaling through the study of rare disease-associated mutations therein.